The DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.
Burden and characteristics of COVID-19 in the United States during 2020
Open accessPublished version of a preprint
Abstract
The COVID-19 pandemic disrupted health systems and economies throughout the world during 2020 and was particularly devastating for the United States, which experienced the highest numbers of reported cases and deaths during 2020 1-3. Many of the epidemiological features responsible for observed rates of morbidity and mortality have been reported 4-8; however, the overall burden and characteristics of COVID-19 in the United States have not been comprehensively quantified. Here we use a data-driven model-inference approach to simulate the pandemic at county-scale in the United States during 2020 and estimate critical, time-varying epidemiological properties underpinning the dynamics of the virus. The pandemic in the United States during 2020 was characterized by national ascertainment rates that increased from 11.3% (95% credible interval (CI): 8.3-15.9%) in March to 24.5% (18.6-32.3%) during December. Population susceptibility at the end of the year was 69.0% (63.6-75.4%), indicating that about one third of the US population had been infected. Community infectious rates, the percentage of people harbouring a contagious infection, increased above 0.8% (0.6-1.0%) before the end of the year, and were as high as 2.4% in some major metropolitan areas. By contrast, the infection fatality rate fell to 0.3% by year's end.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
Wu, J. T., Leung, K., & Leung, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30260-9 · Cited by 4,389
Li, R., Pei, S., Chen, B., Song, Y., Zhang, T., Yang, W., & Shaman, J. (2020) · Science · doi:10.1126/science.abb3221 · Cited by 3,633
Self-citationPrevalence of Asymptomatic SARS-CoV-2 Infection
Oran, D. P., & Topol, E. J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3012 · Cited by 2,348
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility
Arons, M. M., Hatfield, K. M., Reddy, S. C., Kimball, A. A., James, A. E., Jacobs, J. R., Taylor, J., Spicer, K. B., Bardossy, A. C., Oakley, L. P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2008457 · Cited by 2,051
Age-specific mortality and immunity patterns of SARS-CoV-2
O’Driscoll, M., Ribeiro Dos Santos, G., Wang, L., Cummings, D. A. T., Azman, A. S., Paireau, J., Fontanet, A., Cauchemez, S., & Salje, H. (2021) · Nature · doi:10.1038/s41586-020-2918-0 · Cited by 1,210
ESTIMATING PREVALENCE FROM THE RESULTS OF A SCREENING TEST
ROGAN, W. J., & GLADEN, B. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112510 · Cited by 1,001
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Ng, K. W., Faulkner, N., Cornish, G. H., Rosa, A., Harvey, R., Hussain, S., Ulferts, R., Earl, C., Wrobel, A. G., Benton, D. J., et al. (2020) · Science · doi:10.1126/science.abe1107 · Cited by 886
Genomic evidence for reinfection with SARS-CoV-2: a case study
Tillett, R. L., Sevinsky, J. R., Hartley, P. D., Kerwin, H., Crawford, N. F., Gorzalski, A. J., Laverdure, C., Verma, S. C., Rossetto, C. C., Jackson, D. K., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30764-7 · Cited by 755
To, K. K.-W., Hung, I. F.-N., Ip, J. D., Chu, A. W.-H., Chan, W.-M., Tam, A. R., Fong, C. H.-Y., Yuan, S., Tsoi, H.-W., Ng, A. C.-K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1275 · Cited by 746
Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23–May 12, 2020
Havers, F. P., Reed, C., Lim, T., Montgomery, J. M., Klena, J. D., Hall, A. J., Fry, A. M., Cannon, D. L., Chiang, C.-F., Gibbons, A., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.4130 · Cited by 647
Meyerowitz‐Katz, G., & Merone, L. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.1464 · Cited by 582
Buss, L. F., Prete, C. A., Abrahim, C. M. M., Mendrone, A., Salomon, T., de Almeida-Neto, C., França, R. F. O., Belotti, M. C., Carvalho, M. P. S. S., Costa, A. G., et al. (2021) · Science · doi:10.1126/science.abe9728 · Cited by 488
Forecasting seasonal outbreaks of influenza
Shaman, J. L., & Karspeck, A. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208772109 · Cited by 419
Self-citationDifferential effects of intervention timing on COVID-19 spread in the United States
(2020) · doi:10.1126/sciadv.abd6370 · Cited by 366
Self-citationEstimated SARS-CoV-2 Seroprevalence in the US as of September 2020
Bajema, K. L., Wiegand, R. E., Cuffe, K. M., Patel, S. V., Iachan, R., Lim, T. W., Lee, A., Moyse, D., Havers, F. P., Harding, L., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.7976 · Cited by 272
Trends in COVID-19 risk-adjusted mortality rates
Horwitz, L. I., Jones, S. A., Cerfolio, R. J., Francois, F., Greco, J., Rudy, B., & Petrilli, C. M. (2021) · Journal of Hospital Medicine · doi:10.12788/jhm.3552 · Cited by 229
Yang, W., Kandula, S., Huynh, M., Greene, S. K., Wye, G. V., Li, W., Chan, H. T., McGibbon, E., Yeung, A., Olson, D. R., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30769-6 · Cited by 190
Self-citationForecasting the spatial transmission of influenza in the United States
Pei, S., Kandula, S., Yang, W., & Shaman, J. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708856115 · Cited by 182
Self-citationReese, H. E., Iuliano, A. D., Patel, N. N., Garg, S., Kim, L., Silk, B. J., Hall, A. J., Fry, A. M., & Reed, C. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1780 · Cited by 181
Inference of seasonal and pandemic influenza transmission dynamics
Yang, W., Lipsitch, M., & Shaman, J. (2015) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1415012112 · Cited by 171
Self-citationWill SARS-CoV-2 become endemic?
Shaman, J. L., & Galanti, M. (2020) · Science · doi:10.1126/science.abe5960 · Cited by 160
Self-citationRole of meteorological factors in the transmission of SARS-CoV-2 in the United States
Ma, Y., Pei, S., Shaman, J. L., Dubrow, R., & Chen, K. (2021) · Nature Communications · doi:10.1038/s41467-021-23866-7 · Cited by 144
Self-citationKalish, H. R., Klumpp-Thomas, C. A., Hunsberger, S., Baus, H. A., Fay, M. P., Siripong, N., Wang, J., Hicks, J., Mehalko, J. L., Travers, J., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abh3826 · Cited by 137
Self, W. H., Tenforde, M. W., Stubblefield, W. B., Feldstein, L. R., Steingrub, J. S., Shapiro, N. I., Ginde, A. A., Prekker, M. E., Brown, S. M., Peltan, I. D., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6947a2 · Cited by 135
Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
Choe, P. G., Kang, C. K., Suh, H. J., Jung, J., Song, K., Bang, J. H., Kim, E. S., Kim, H. B., Park, S., Kim, N. J., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2701.203515 · Cited by 116
Riley, S., Kwok, K. O., Wu, K. M., Ning, D. Y., Cowling, B. J., Wu, J. T. K., Ho, L., Tsang, T., Lo, S., Chu, D. K. W., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000442 · Cited by 108
Ensemble forecast of human West Nile virus cases and mosquito infection rates
DeFelice, N., Little, E., Campbell, S. R., & Shaman, J. L. (2017) · Nature Communications · doi:10.1038/ncomms14592 · Cited by 107
Self-citationInitial Simulation of SARS-CoV2 Spread and Intervention Effects in the Continental USPreprint
Pei, S., & Shaman, J. L. (2020) · medRxiv · doi:10.1101/2020.03.21.20040303 · Cited by 98
Self-citationReconstructing influenza incidence by deconvolution of daily mortality time series
Goldstein, E., Dushoff, J., Ma, J., Plotkin, J. B., Earn, D. J. D., & Lipsitch, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902958106 · Cited by 94
First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020
Fiorentini, S., Messali, S., Zani, A., Caccuri, F., Giovanetti, M., Ciccozzi, M., & Caruso, A. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00007-4 · Cited by 88
Report 34: COVID-19 infection fatality ratio: estimates from seroprevalence
Brazeau, N., Verity, R., Jenks, S. J., Fu, H. J., Whittaker, C., Winskill, P., Dorigatti, I., Walker, P. G. T., Riley, S., Schnekenberg, R. P., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/83545 · Cited by 86
Shioda, K., Lau, M. S. Y., Kraay, A. N. M., Nelson, K., Siegler, A. J., Sullivan, P. S., Collins, M. H., Weitz, J. S., & Lopman, B. A. (2021) · Epidemiology · doi:10.1097/ede.0000000000001361 · Cited by 76
Hallifax, R., Porter, B., Elder, P. J., Evans, S. B., Turnbull, C. D., Hynes, G., Lardner, R., Archer, K., Bettinson, H., Nickol, A. H., et al. (2020) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2020-000678 · Cited by 66
Retrospective Parameter Estimation and Forecast of Respiratory Syncytial Virus in the United States
Reis, J., & Shaman, J. L. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005133 · Cited by 61
Self-citationAn Ensemble Smoother with Error Estimates
van Leeuwen, P. J. (2001) · Monthly Weather Review · doi:10.1175/1520-0493(2001)129 · Cited by 55
Projection of COVID-19 Cases and Deaths in the US as Individual States Re-open May 4, 2020Preprint
Yamana, T. K., Pei, S., Kandula, S., & Shaman, J. L. (2020) · medRxiv · doi:10.1101/2020.05.04.20090670 · Cited by 42
Self-citationLefrancq, N., Paireau, J., Hozé, N., Courtejoie, N., Yazdanpanah, Y., Bouadma, L., Boëlle, P., Chéreau, F., Salje, H., & Cauchemez, S. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100087 · Cited by 41
Shioda, K., Lau, M. S. Y., Kraay, A. N. M., et al. (2020) · medRxiv · doi:10.1101/2020.11.13.20231266 · Cited by 32
Timing the SARS-CoV-2 Index Case in Hubei ProvincePreprint
Pekar, J. E., Worobey, M., Moshiri, N., Scheffler, K., & Wertheim, J. O. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.20.392126 · Cited by 16
Pandemic fatigue impedes mitigation of COVID-19 in Hong KongPreprint
Du, Z., Wang, L., Shan, S., Lam, D., Tsang, T. K., Xiao, J., Gao, H., Yang, B., Ali, S. T., Pei, S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-591241/v1 · Cited by 5
Self-citation
Cited by
Sorted by citations
The Lancet Commission on lessons for the future from the COVID-19 pandemic
Sachs, J. D., Karim, S. S. A., Aknin, L., Allen, J., Brosbøl, K., Colombo, F., Barron, G. C., Espinosa, M. F., Gaspar, V., Gaviria, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01585-9 · Cited by 842
Human genetic and immunological determinants of critical COVID-19 pneumonia
Zhang, Q., Bastard, P., Effort, C. H. G., Karbuz, A., Gervais, A., Tayoun, A. N. A., Aiuti, A., Bélot, A., Bolze, A., Gaudet, A., et al. (2022) · Nature · doi:10.1038/s41586-022-04447-0 · Cited by 377
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Manry, J., Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., Michailidis, E., Hoffmann, H.-H., Eto, S., García-Prat, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2200413119 · Cited by 205
Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis
Danwang, C., Noubiap, J. J., Robert, A. R., & Yombi, J. C. (2022) · AIDS Research and Therapy · doi:10.1186/s12981-021-00427-y · Cited by 155
Context-specific emergence and growth of the SARS-CoV-2 Delta variant
McCrone, J. T., Hill, V., Bajaj, S., Pena, R. E., Lambert, B. C., Inward, R. P. D., Bhatt, S., Volz, E., Ruis, C., Dellicour, S., et al. (2022) · Nature · doi:10.1038/s41586-022-05200-3 · Cited by 128
Metadata
- Authors
- Pei, S., Yamana, T. K., Kandula, S., Galanti, M., & Shaman, J.
- Affiliations
- Columbia University (US)
- Corresponding author
- Pei, Sen
- Shaman, Jeffrey
- Venue
- Nature
- Published
- 2021-08-26
- Volume
- 598
- Issue
- 7880
- Pages
- 338-341
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3195051481
- Cited by
- 190
- References
- 47
- Citations by year
- 2026: 6 · 2025: 20 · 2024: 31 · 2023: 58 · 2022: 64 · 2021: 11
- FWCI
- 15.92
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-12-17)
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- medRxiv (acceptedVersion, cc-by-nd)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Science Foundation (2027369)
- Mailman School of Public Health, Columbia University
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Physical Sciences › Mathematics › Applied Mathematics › Mathematical and Theoretical Epidemiology and Ecology Models
- Keywords
- COVID-19 pandemic, SARS-CoV-2, population susceptibility, infection fatality rate, disease transmission dynamics, human mobility, United States
- MeSH terms
- COVID-19, SARS-CoV-2, Calibration, Humans, United States, Incidence, Prevalence, Cost of Illness, Basic Reproduction Number, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
